Calian Group Ltd.CGY.TO
Industrials · Commercial & Professional Services · TSX · Canada · calian.com
Calian Group Ltd. is an Ottawa-based provider of business services and solutions operating through four segments: Advanced Technologies, Health, Learning, and IT and Cyber Solutions. The company delivers communication and connectivity products, cybersecurity solutions, healthcare services, enterprise IT, and corporate training to government, defense, and commercial clients in Canada and internationally.
Key ratios
Operating cash flow growth
-34.9%TTM
2025
-47.9%2024
53.6%2023
31.6%
EPS growth
489.6%TTM
2025
89.3%2024
-42.2%2023
35.3%
FCF / Sales
4.6%TTM
2025
4.5%2024
10.1%2023
7.3%
Net margin
3.3%TTM
2025
2.7%2024
1.5%2023
2.9%
ROA
2.8%TTM
2025
2.4%2024
4.4%2023
4.2%
ROE
8.2%TTM
2025
6.3%2024
3.4%2023
6.0%
Revenue growth
5.9%TTM
2025
3.7%2024
13.4%2023
13.1%
Recent news
Calian and CIMVHR establish a Military & Public Safety Family Health Research Scholarship in honour of Professor Nicola T. Fear
Calian confirms Will Majic as Chief Financial Officer and appoints Kristine McTaggart President, Essential Industries
Calian completes sale of U.S. commercial IT business to Trace3
Calian and SkyFall Sign Strategic Agreement to Advance Drone-Enabled Defence Training and Operational Readiness
Calian Announces Normal Course Issuer Bid and Filing of Short Form Base Shelf Prospectus
Calian Announces Agreement to Sell its U.S. Commercial IT Business to Trace3
Calian Reports Record Results for the Third Quarter of Fiscal 2026
Calian to Hold Conference Call Following Announcement of Third Quarter FY 2026 Results
Calian Enters Definitive Agreement to Acquire Galaxy Broadband, Expanding Communications and Connectivity Capabilities Across Canada
Calian Reports Record Results for the Second Quarter of Fiscal 2026
Track CGY.TO in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer